Quick summary

Yerba Mate (Ilex paraguariensis) is a South American plant traditionally used as a herbal infusion. It contains bioactive compounds such as chlorogenic acids, quercetin, and rutin, which have demonstrated antioxidant and anti-inflammatory properties. It is popularly consumed for potential effects on metabolic health, weight management, and cardiovascular parameters. However, clinical evidence is preliminary, and further rigorous studies are needed.

What is it

Yerba Mate is a plant native to South America, commonly prepared and consumed as a hot or cold infusion. It is appreciated culturally and traditionally for its stimulating effects and has gained interest for its nutrient and bioactive compound content.

Traditional uses

Traditionally, Yerba Mate has been consumed as a beverage for its mild stimulant properties and as a social drink. It is also used to support general wellbeing and is reputed for aiding digestion and enhancing alertness.

Active compounds

  • Chlorogenic acids
  • Quercetin
  • Rutin
  • Caffeine
  • Polyphenols and other flavonoids

Potential benefits with evidence levels

  • Anti-inflammatory and antioxidant effects relevant to rheumatoid arthritis (Preliminary human and animal studies): Small clinical and observational studies, as well as in vitro and animal research, suggest yerba mate may reduce inflammatory markers (e.g., C-reactive protein, interleukin-6) and improve oxidative balance. No randomized controlled trials specifically in rheumatoid arthritis patients have been conducted.
  • Improvement in glycemic control in pre-diabetes (Systematic review and meta-analysis of randomized controlled trials): Meta-analysis of 13 RCTs indicates yerba mate consumption may reduce postprandial glucose, HbA1c, and insulin resistance indicators in pre-diabetic individuals. Effects on lipid profiles and weight management were not significant.
  • Cardiometabolic effects in healthy and at-risk subjects (Randomized controlled trial): One RCT found that moderate yerba mate intake reduced blood pressure, inflammatory cytokines, and LDL cholesterol in normocholesterolemic subjects. Effects on body fat percentage were noted in healthy but not hypercholesterolemic individuals.
  • Weight management and obesity adjunct (Review of clinical and animal studies): Yerba mate extracts have shown potential anti-obesity effects, with some evidence of weight reduction and impact on obesity-related metabolic pathways. Findings remain preliminary and require further confirmation.
  • Potential antioxidant and hypolipidemic properties (Preclinical and limited clinical data): The plant contains bioactive compounds linked with antioxidant, anti-inflammatory, and lipid-regulating effects, though consistent clinical evidence for lipid-lowering or antioxidant effects is modest.

Side effects

  • Mild gastrointestinal symptoms (e.g., discomfort)
  • Cardiovascular symptoms such as tachycardia and angina reported in some cases
  • Mucosal irritation (e.g., mouth and throat)
  • Insomnia and headache have also been noted
  • Rare hepatotoxicity appears more associated with green tea catechins than yerba mate itself

Drug interactions

Potential interactions may occur through cytochrome P450 pathways. Yerba Mate’s caffeine and flavonoid content could modulate the pharmacokinetics of drugs metabolized by CYP enzymes. Specific herb-drug interaction studies are limited; therefore, caution is advised, especially when combined with medications with narrow therapeutic windows or significant CYP metabolism.

Who should avoid it

Individuals with cardiovascular disease or sensitivity to caffeine should exercise caution when consuming yerba mate. Due to insufficient safety data, pregnant and breastfeeding women are advised to avoid or limit consumption. There are no formal contraindications established but cautious use is recommended for certain populations.

Evidence limitations

  • Many human studies have small sample sizes, are observational, or of short duration
  • Significant heterogeneity exists among study designs, yerba mate preparations, and outcome measures
  • Animal study results may not fully translate to humans due to species differences
  • Methodological limitations and potential risks of bias are present in some clinical trials
  • Lack of long-term randomized controlled trials for many clinical uses
  • Limited data on interactions with drugs, safety in special populations, and standardized dosing

References

Last reviewed

June 2025

Disclaimer: This page is for informational purposes only and does not constitute medical advice. The effects of Yerba Mate may vary among individuals, and more high-quality research is needed to confirm potential benefits and safety. Always consult a healthcare professional before starting any new supplement, especially if you have existing health conditions or are taking medications.